Hangming Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hangming Dong has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Shaoxi Cai
Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University
33 shared publications Jinming Zhang
25 shared publicationsHaohua Huang
24 shared publicationsDongyu Liu
16 shared publicationsJinzhong Zhuo
13 shared publicationsQi Yu
13 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Elsevier in Materials & Design
- Vol. 272
Ginseng-derived nanoparticles enhance budesonide therapy and attenuate systemic toxicity in experimental asthma
- 29 October 2026
- Published by Elsevier in Materials & Design
- Vol. 272
Open AccessGinseng-derived nanoparticles enhance budesonide therapy and attenuate systemic toxicity in experimental asthma
- Open Access
- 18 July 2026
- Published by Elsevier in Redox Biology
- Vol. 96
BMAL1 deficiency exacerbates HDM-induced asthma by promoting JUN-mediated lipid peroxidation and airway epithelial ferroptosis
- 18 July 2026
- Published by Elsevier in Redox Biology
- Vol. 96
Open AccessBMAL1 deficiency exacerbates HDM-induced asthma by promoting JUN-mediated lipid peroxidation and airway epithelial ferroptosis
- Open Access
- 23 June 2026
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
H3K18 lactylation promotes allergic airway inflammation in asthma via a CSF1/CSF1R/MAPK autocrine axis
Metabolic reprogramming of airway epithelial cells is a hallmark of asthma, yet the mechanisms by which altered metabolism drives inflammation remain largely unknown. Histone lactylation, a recently identified metabolism-derived epigenetic modification, may provide a mechanistic link. Clinical specimens and single-cell RNA sequencing (scRNA-seq) were analyzed to map the metabolic landscape of asthma. Histone lactylation in airway epithelial cells was assessed by western blotting and immunofluorescence. Functional roles of histone lactylation were evaluated via modulation of glycolysis, lactate availability, or P300 expression. Chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) were performed to identify transcriptional targets of H3K18 lactylation (H3K18la). Glycolysis and histone lactylation, particularly H3K18la, were significantly elevated in the airway epithelial cells of asthma. Inhibition of glycolysis or P300 knockdown attenuated the inflammatory response by suppressing histone lactylation; whereas lactate supplementation exacerbated inflammation by promoting histone lactylation. H3K18la accumulated at the CSF1R promoter, directly enhancing its transcription and establishing a CSF1/CSF1R/MAPK autocrine positive feedback axis that positions airway epithelial cells as an upstream driver and inflammatory amplifier in allergic airway inflammation. This study defines a glycolysis-histone lactylation-CSF1R signaling axis that links epithelial metabolic reprogramming to sustained inflammatory gene activation in asthma, highlighting histone lactylation as a potential therapeutic target for allergic airway inflammation.
- 23 June 2026
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
Open AccessH3K18 lactylation promotes allergic airway inflammation in asthma via a CSF1/CSF1R/MAPK autocrine axis
Metabolic reprogramming of airway epithelial cells is a hallmark of asthma, yet the mechanisms by which altered metabolism drives inflammation remain largely unknown. Histone lactylation, a recently identified metabolism-derived epigenetic modification, may provide a mechanistic link. Clinical specimens and single-cell RNA sequencing (scRNA-seq) were analyzed to map the metabolic landscape of asthma. Histone lactylation in airway epithelial cells was assessed by western blotting and immunofluorescence. Functional roles of histone lactylation were evaluated via modulation of glycolysis, lactate availability, or P300 expression. Chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) were performed to identify transcriptional targets of H3K18 lactylation (H3K18la). Glycolysis and histone lactylation, particularly H3K18la, were significantly elevated in the airway epithelial cells of asthma. Inhibition of glycolysis or P300 knockdown attenuated the inflammatory response by suppressing histone lactylation; whereas lactate supplementation exacerbated inflammation by promoting histone lactylation. H3K18la accumulated at the CSF1R promoter, directly enhancing its transcription and establishing a CSF1/CSF1R/MAPK autocrine positive feedback axis that positions airway epithelial cells as an upstream driver and inflammatory amplifier in allergic airway inflammation. This study defines a glycolysis-histone lactylation-CSF1R signaling axis that links epithelial metabolic reprogramming to sustained inflammatory gene activation in asthma, highlighting histone lactylation as a potential therapeutic target for allergic airway inflammation.
- 8 June 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 254, 62-77
ac4C modification of PDK4 by NAT10 promotes pulmonary fibrosis by reprogramming mitochondrial dynamics in fibroblasts
- 8 June 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 254, 62-77
ac4C modification of PDK4 by NAT10 promotes pulmonary fibrosis by reprogramming mitochondrial dynamics in fibroblasts
- Open Access
- 10 March 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
The association between body roundness index and asthma risk in middle-aged and elderly people: a retrospective cohort study based on CHARLS database
Background: The prevalence of asthma is rising globally, posing a significant public health burden. While obesity is a well-established risk factor for asthma, traditional metrics like Body Mass Index (BMI) have limitations in distinguishing visceral adiposity. The Body Roundness Index (BRI) is a novel geometric indicator of central obesity, but its longitudinal association with asthma risk in middle-aged and elderly populations remains unclear. Methods: We conducted a retrospective cohort study using data from the China Health and Retirement Longitudinal Study (CHARLS) covering the period from 2011 to 2020. A total of 7,754 participants aged 45 years and older, free of respiratory diseases at baseline, were included. Multivariable Cox proportional hazards models and restricted cubic spline (RCS) analyses were employed to evaluate the association between BRI and the incidence of asthma. Results: During a 7-year follow-up, 521 incident asthma cases were identified. In fully adjusted models, elevated BRI was significantly associated with an increased risk of asthma (Hazard Ratio [HR] = 1.39, 95% CI: 1.388–1.393 per SD increase). RCS analysis revealed a non-linear U-shaped relationship with a distinct inflection point at a BRI of 4.12. Beyond this threshold, the risk of asthma increased substantially (HR = 1.75, 95% CI: 1.34–2.27). Subgroup analyses demonstrated that the association was more pronounced in females and urban residents. Conclusion: BRI is significantly associated with the risk of asthma in middle-aged and elderly Chinese adults, exhibiting a non-linear dose-response relationship. As a superior marker of visceral adiposity, BRI may serve as a simple and effective tool for identifying high-risk individuals, particularly women, to facilitate early screening and prevention strategies for asthma.
- 10 March 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessThe association between body roundness index and asthma risk in middle-aged and elderly people: a retrospective cohort study based on CHARLS database
Background: The prevalence of asthma is rising globally, posing a significant public health burden. While obesity is a well-established risk factor for asthma, traditional metrics like Body Mass Index (BMI) have limitations in distinguishing visceral adiposity. The Body Roundness Index (BRI) is a novel geometric indicator of central obesity, but its longitudinal association with asthma risk in middle-aged and elderly populations remains unclear. Methods: We conducted a retrospective cohort study using data from the China Health and Retirement Longitudinal Study (CHARLS) covering the period from 2011 to 2020. A total of 7,754 participants aged 45 years and older, free of respiratory diseases at baseline, were included. Multivariable Cox proportional hazards models and restricted cubic spline (RCS) analyses were employed to evaluate the association between BRI and the incidence of asthma. Results: During a 7-year follow-up, 521 incident asthma cases were identified. In fully adjusted models, elevated BRI was significantly associated with an increased risk of asthma (Hazard Ratio [HR] = 1.39, 95% CI: 1.388–1.393 per SD increase). RCS analysis revealed a non-linear U-shaped relationship with a distinct inflection point at a BRI of 4.12. Beyond this threshold, the risk of asthma increased substantially (HR = 1.75, 95% CI: 1.34–2.27). Subgroup analyses demonstrated that the association was more pronounced in females and urban residents. Conclusion: BRI is significantly associated with the risk of asthma in middle-aged and elderly Chinese adults, exhibiting a non-linear dose-response relationship. As a superior marker of visceral adiposity, BRI may serve as a simple and effective tool for identifying high-risk individuals, particularly women, to facilitate early screening and prevention strategies for asthma.
- Open Access
- 10 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 6471-6488
Diagnostic model and identification of IGFBP2 as an aging-related biomarker and therapeutic target for systemic sclerosis-associated interstitial lung disease through integrated bioinformatics and machine learning approaches
Background: Cellular senescence is a critical contributor to the pathogenesis of systemic sclerosis-associated interstitial lung disease (SSc-ILD). However, the roles of aging-related genes in disease onset and progression remain unclear. We aimed to identify the clinical features and senescence-associated genetic signatures of SSc-ILD and validate the role of insulin-like growth factor-binding protein 2 (IGFBP2) in basal cell senescence and fibrotic progression. Methods: The cohort comprised 106 patients with SSc hospitalized between January 2020 and December 2023 who were divided into SSc-ILD ( n = 73) and SSc-NILD ( n = 33) groups. Baseline clinical data were compared, and independent risk factors were identified using stepwise multivariate logistic regression analysis to develop a clinical nomogram. Gene expression datasets were downloaded from the Gene Expression Omnibus (GSE231693 as the training set; GSE48149, GSE76808, and GSE81292 as the validation sets). Aging-related genes were retrieved from CellAge and GeneCard databases. Differentially expressed genes (DEGs) were identified and subjected to a functional enrichment analysis. Weighted gene co-expression network analysis combined with the least absolute shrinkage and selection operator, random forest, and support vector machine–recursive feature elimination algorithms identified hub genes. A senescence-related gene diagnostic nomogram was developed, and its receiver operating characteristics were validated. The biomarkers were experimentally validated in a bleomycin-induced SSc-ILD mouse model using immunofluorescence, quantitative polymerase chain reaction, and western blotting. Single-cell RNA sequencing (GSE159354) was used to assess IGFBP2 expression across lung cell populations. IGFBP2 was selectively knocked down in basal cells using AAV6-IGFBP2 delivered shRNA to evaluate its fibrotic role. Results: The independent risk factors for SSc-ILD included age ≥50 years, diffuse cutaneous involvement, hyperlipidemia, dyspnea, and anti-Scl-70 positivity. Among the 1061 aging-related genes, 68 were identified as aging-related DEGs, of which four were identified as hub genes (IGFBP2, ABCB1, CXCR2, and MEOX1). The gene-based nomogram demonstrated a strong diagnostic performance (area under the curve = 0.92). IGFBP2 is upregulated in fibrotic lungs and localized to basal and ciliated cells, whereas its targeted knockdown attenuates pulmonary fibrosis. Conclusion: Our results indicate that IGFBP2 is a key senescence-associated biomarker of SSc-ILD. The integrative approach used in this study provides a robust framework for the discovery of therapeutic targets.
- 10 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 6471-6488
Open AccessDiagnostic model and identification of IGFBP2 as an aging-related biomarker and therapeutic target for systemic sclerosis-associated interstitial lung disease through integrated bioinformatics and machine learning approaches
Background: Cellular senescence is a critical contributor to the pathogenesis of systemic sclerosis-associated interstitial lung disease (SSc-ILD). However, the roles of aging-related genes in disease onset and progression remain unclear. We aimed to identify the clinical features and senescence-associated genetic signatures of SSc-ILD and validate the role of insulin-like growth factor-binding protein 2 (IGFBP2) in basal cell senescence and fibrotic progression. Methods: The cohort comprised 106 patients with SSc hospitalized between January 2020 and December 2023 who were divided into SSc-ILD ( n = 73) and SSc-NILD ( n = 33) groups. Baseline clinical data were compared, and independent risk factors were identified using stepwise multivariate logistic regression analysis to develop a clinical nomogram. Gene expression datasets were downloaded from the Gene Expression Omnibus (GSE231693 as the training set; GSE48149, GSE76808, and GSE81292 as the validation sets). Aging-related genes were retrieved from CellAge and GeneCard databases. Differentially expressed genes (DEGs) were identified and subjected to a functional enrichment analysis. Weighted gene co-expression network analysis combined with the least absolute shrinkage and selection operator, random forest, and support vector machine–recursive feature elimination algorithms identified hub genes. A senescence-related gene diagnostic nomogram was developed, and its receiver operating characteristics were validated. The biomarkers were experimentally validated in a bleomycin-induced SSc-ILD mouse model using immunofluorescence, quantitative polymerase chain reaction, and western blotting. Single-cell RNA sequencing (GSE159354) was used to assess IGFBP2 expression across lung cell populations. IGFBP2 was selectively knocked down in basal cells using AAV6-IGFBP2 delivered shRNA to evaluate its fibrotic role. Results: The independent risk factors for SSc-ILD included age ≥50 years, diffuse cutaneous involvement, hyperlipidemia, dyspnea, and anti-Scl-70 positivity. Among the 1061 aging-related genes, 68 were identified as aging-related DEGs, of which four were identified as hub genes (IGFBP2, ABCB1, CXCR2, and MEOX1). The gene-based nomogram demonstrated a strong diagnostic performance (area under the curve = 0.92). IGFBP2 is upregulated in fibrotic lungs and localized to basal and ciliated cells, whereas its targeted knockdown attenuates pulmonary fibrosis. Conclusion: Our results indicate that IGFBP2 is a key senescence-associated biomarker of SSc-ILD. The integrative approach used in this study provides a robust framework for the discovery of therapeutic targets.
- Open Access
- 28 January 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 310, 119782
5-methoxyindole-3-carboxaldehyde attenuates alveolar type II epithelial cell senescence induced by exposure to polystyrene microplastics in pulmonary fibrosis via PI3K/AKT/mTOR signaling pathway
- 28 January 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 310, 119782
Open Access5-methoxyindole-3-carboxaldehyde attenuates alveolar type II epithelial cell senescence induced by exposure to polystyrene microplastics in pulmonary fibrosis via PI3K/AKT/mTOR signaling pathway
- 16 December 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 338 (Pt 2) , 149695
Bacterial cellulose repairs asthmatic epithelial injury by reprogramming CDS1-mediated phosphatidylinositol metabolism to inhibit PI3K/AKT signaling
- 16 December 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 338 (Pt 2) , 149695
Bacterial cellulose repairs asthmatic epithelial injury by reprogramming CDS1-mediated phosphatidylinositol metabolism to inhibit PI3K/AKT signaling
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (3) , e251296
Dynamic Chest Radiography as an Alternative to Pulmonary Function Tests for Chronic Obstructive Pulmonary Disease
A dynamic chest radiography (DCR)–based nomogram demonstrated robust diagnostic performance in identifying chronic obstructive pulmonary disease, suggesting DCR as an efficacious alternative to standard pulmonary function tests for screening.
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (3) , e251296
Dynamic Chest Radiography as an Alternative to Pulmonary Function Tests for Chronic Obstructive Pulmonary Disease
A dynamic chest radiography (DCR)–based nomogram demonstrated robust diagnostic performance in identifying chronic obstructive pulmonary disease, suggesting DCR as an efficacious alternative to standard pulmonary function tests for screening.
- Open Access
- 10 October 2025
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 21 (14) , 6482-6500
Disruption of the Clock Component BMAL1 in HDM-induced Asthma Causes GC Resistance in Airway Epithelial Cells by Regulating GR Phosphorylation through the DUSP4-p38MAPK Pathway
Circadian rhythm disruption has been increasingly implicated in asthma and glucocorticoid (GC) resistance. In this study, we discovered that disruption of the brain and muscle ARNT-like 1 (BMAL1), a significant activator of the circadian clock transcription, not only exacerbated allergic inflammation but also induced GC resistance. The absence of BMAL1 intensified airway inflammation by activating the NF-κB and AP-1 pathways and also impaired the anti-inflammatory effect of GC. Our findings indicated that the deletion of BMAL1 reduced the phosphorylation level of the GC receptor (GR-Ser211), which has a direct effect on the efficacy of GC and serves as a key indicator of GR activation. Additionally, BMAL1 has a negative regulatory effect on the phosphatase dual specificity protein phosphatase 4 (DUSP4) of p38 mitogen-activated protein kinase (p38MAPK), which plays a crucial role in the phosphorylation of GR. Consequently, our findings suggest that the absence of BMAL1 results in the resistance of airway epithelial cells to GC due to the inhibition of GR phosphorylation via the DUSP4-p38MAPK axis in HDM-induced asthma. We demonstrated that the inhibition of DUSP4 restored GR activation and improved GC responsiveness, highlighting a potential therapeutic strategy for GC resistance driven by circadian disruption. Regulating the sleep disorder and circadian rhythm of patients with asthma could become a potential treatment to increase GC sensitivity.
- 10 October 2025
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 21 (14) , 6482-6500
Open AccessDisruption of the Clock Component BMAL1 in HDM-induced Asthma Causes GC Resistance in Airway Epithelial Cells by Regulating GR Phosphorylation through the DUSP4-p38MAPK Pathway
Circadian rhythm disruption has been increasingly implicated in asthma and glucocorticoid (GC) resistance. In this study, we discovered that disruption of the brain and muscle ARNT-like 1 (BMAL1), a significant activator of the circadian clock transcription, not only exacerbated allergic inflammation but also induced GC resistance. The absence of BMAL1 intensified airway inflammation by activating the NF-κB and AP-1 pathways and also impaired the anti-inflammatory effect of GC. Our findings indicated that the deletion of BMAL1 reduced the phosphorylation level of the GC receptor (GR-Ser211), which has a direct effect on the efficacy of GC and serves as a key indicator of GR activation. Additionally, BMAL1 has a negative regulatory effect on the phosphatase dual specificity protein phosphatase 4 (DUSP4) of p38 mitogen-activated protein kinase (p38MAPK), which plays a crucial role in the phosphorylation of GR. Consequently, our findings suggest that the absence of BMAL1 results in the resistance of airway epithelial cells to GC due to the inhibition of GR phosphorylation via the DUSP4-p38MAPK axis in HDM-induced asthma. We demonstrated that the inhibition of DUSP4 restored GR activation and improved GC responsiveness, highlighting a potential therapeutic strategy for GC resistance driven by circadian disruption. Regulating the sleep disorder and circadian rhythm of patients with asthma could become a potential treatment to increase GC sensitivity.